NCI's Advanced Technology Center (ATC), established for the implementation of novel technologies to address biological, clinical, and genetic questions pertinent to human cancers, includes the NCI Core Genotyping Facility which is overseen by DCEG.
The aim of the CGF is to meet the genotyping and DNA sequencing needs of the DCEG and NCI's Center for Cancer Research. The facility performs high-throughput genotyping and sequencing to support genetic analysis for a broad range of projects for the intramural research program of the NCI.
| Lambrechts, Diether; Truong, Therese; Justenhoven, Christina et al. (2012) 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat 33:1123-32 |
| Erichsen, H C; Chanock, S J (2004) SNPs in cancer research and treatment. Br J Cancer 90:747-51 |
| Packer, Bernice R; Yeager, Meredith; Staats, Brian et al. (2004) SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res 32:D528-32 |
| Hughes, Austin L; Packer, Bernice; Welch, Robert et al. (2003) Widespread purifying selection at polymorphic sites in human protein-coding loci. Proc Natl Acad Sci U S A 100:15754-7 |
| Haque, Kashif A; Pfeiffer, Ruth M; Beerman, Michael B et al. (2003) Performance of high-throughput DNA quantification methods. BMC Biotechnol 3:20 |
